Clinical Trial Update: Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating goserelin acetate for preserving ovarian function in premenopausal women with breast cancer undergoing chemotherapy has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer, Ovarian Function | Phase 3 | Status: WITHDRAWN